Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Artificial Intelligence-driven Drug Development
1.2 Key Market Segments
1.2.1 Artificial Intelligence-driven Drug Development Segment by Type
1.2.2 Artificial Intelligence-driven Drug Development Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Artificial Intelligence-driven Drug Development Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Artificial Intelligence-driven Drug Development Market Competitive Landscape
3.1 Global Artificial Intelligence-driven Drug Development Revenue Market Share by Company (2019-2024)
3.2 Artificial Intelligence-driven Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Artificial Intelligence-driven Drug Development Market Size Sites, Area Served, Product Type
3.4 Artificial Intelligence-driven Drug Development Market Competitive Situation and Trends
3.4.1 Artificial Intelligence-driven Drug Development Market Concentration Rate
3.4.2 Global 5 and 10 Largest Artificial Intelligence-driven Drug Development Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Artificial Intelligence-driven Drug Development Value Chain Analysis
4.1 Artificial Intelligence-driven Drug Development Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Artificial Intelligence-driven Drug Development Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Artificial Intelligence-driven Drug Development Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Artificial Intelligence-driven Drug Development Market Size Market Share by Type (2019-2024)
6.3 Global Artificial Intelligence-driven Drug Development Market Size Growth Rate by Type (2019-2024)
7 Artificial Intelligence-driven Drug Development Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Artificial Intelligence-driven Drug Development Market Size (M USD) by Application (2019-2024)
7.3 Global Artificial Intelligence-driven Drug Development Market Size Growth Rate by Application (2019-2024)
8 Artificial Intelligence-driven Drug Development Market Segmentation by Region
8.1 Global Artificial Intelligence-driven Drug Development Market Size by Region
8.1.1 Global Artificial Intelligence-driven Drug Development Market Size by Region
8.1.2 Global Artificial Intelligence-driven Drug Development Market Size Market Share by Region
8.2 North America
8.2.1 North America Artificial Intelligence-driven Drug Development Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Artificial Intelligence-driven Drug Development Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Artificial Intelligence-driven Drug Development Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Artificial Intelligence-driven Drug Development Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Artificial Intelligence-driven Drug Development Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 IBM
9.1.1 IBM Artificial Intelligence-driven Drug Development Basic Information
9.1.2 IBM Artificial Intelligence-driven Drug Development Product Overview
9.1.3 IBM Artificial Intelligence-driven Drug Development Product Market Performance
9.1.4 IBM Artificial Intelligence-driven Drug Development SWOT Analysis
9.1.5 IBM Business Overview
9.1.6 IBM Recent Developments
9.2 Exscientia
9.2.1 Exscientia Artificial Intelligence-driven Drug Development Basic Information
9.2.2 Exscientia Artificial Intelligence-driven Drug Development Product Overview
9.2.3 Exscientia Artificial Intelligence-driven Drug Development Product Market Performance
9.2.4 IBM Artificial Intelligence-driven Drug Development SWOT Analysis
9.2.5 Exscientia Business Overview
9.2.6 Exscientia Recent Developments
9.3 Google(Alphabet)
9.3.1 Google(Alphabet) Artificial Intelligence-driven Drug Development Basic Information
9.3.2 Google(Alphabet) Artificial Intelligence-driven Drug Development Product Overview
9.3.3 Google(Alphabet) Artificial Intelligence-driven Drug Development Product Market Performance
9.3.4 IBM Artificial Intelligence-driven Drug Development SWOT Analysis
9.3.5 Google(Alphabet) Business Overview
9.3.6 Google(Alphabet) Recent Developments
9.4 Microsoft
9.4.1 Microsoft Artificial Intelligence-driven Drug Development Basic Information
9.4.2 Microsoft Artificial Intelligence-driven Drug Development Product Overview
9.4.3 Microsoft Artificial Intelligence-driven Drug Development Product Market Performance
9.4.4 Microsoft Business Overview
9.4.5 Microsoft Recent Developments
9.5 Atomwise
9.5.1 Atomwise Artificial Intelligence-driven Drug Development Basic Information
9.5.2 Atomwise Artificial Intelligence-driven Drug Development Product Overview
9.5.3 Atomwise Artificial Intelligence-driven Drug Development Product Market Performance
9.5.4 Atomwise Business Overview
9.5.5 Atomwise Recent Developments
9.6 Schrodinger
9.6.1 Schrodinger Artificial Intelligence-driven Drug Development Basic Information
9.6.2 Schrodinger Artificial Intelligence-driven Drug Development Product Overview
9.6.3 Schrodinger Artificial Intelligence-driven Drug Development Product Market Performance
9.6.4 Schrodinger Business Overview
9.6.5 Schrodinger Recent Developments
9.7 Aitia
9.7.1 Aitia Artificial Intelligence-driven Drug Development Basic Information
9.7.2 Aitia Artificial Intelligence-driven Drug Development Product Overview
9.7.3 Aitia Artificial Intelligence-driven Drug Development Product Market Performance
9.7.4 Aitia Business Overview
9.7.5 Aitia Recent Developments
9.8 Insilico Medicine
9.8.1 Insilico Medicine Artificial Intelligence-driven Drug Development Basic Information
9.8.2 Insilico Medicine Artificial Intelligence-driven Drug Development Product Overview
9.8.3 Insilico Medicine Artificial Intelligence-driven Drug Development Product Market Performance
9.8.4 Insilico Medicine Business Overview
9.8.5 Insilico Medicine Recent Developments
9.9 NVIDIA
9.9.1 NVIDIA Artificial Intelligence-driven Drug Development Basic Information
9.9.2 NVIDIA Artificial Intelligence-driven Drug Development Product Overview
9.9.3 NVIDIA Artificial Intelligence-driven Drug Development Product Market Performance
9.9.4 NVIDIA Business Overview
9.9.5 NVIDIA Recent Developments
9.10 XtalPi
9.10.1 XtalPi Artificial Intelligence-driven Drug Development Basic Information
9.10.2 XtalPi Artificial Intelligence-driven Drug Development Product Overview
9.10.3 XtalPi Artificial Intelligence-driven Drug Development Product Market Performance
9.10.4 XtalPi Business Overview
9.10.5 XtalPi Recent Developments
9.11 BPGbio
9.11.1 BPGbio Artificial Intelligence-driven Drug Development Basic Information
9.11.2 BPGbio Artificial Intelligence-driven Drug Development Product Overview
9.11.3 BPGbio Artificial Intelligence-driven Drug Development Product Market Performance
9.11.4 BPGbio Business Overview
9.11.5 BPGbio Recent Developments
9.12 Owkin
9.12.1 Owkin Artificial Intelligence-driven Drug Development Basic Information
9.12.2 Owkin Artificial Intelligence-driven Drug Development Product Overview
9.12.3 Owkin Artificial Intelligence-driven Drug Development Product Market Performance
9.12.4 Owkin Business Overview
9.12.5 Owkin Recent Developments
9.13 CytoReason
9.13.1 CytoReason Artificial Intelligence-driven Drug Development Basic Information
9.13.2 CytoReason Artificial Intelligence-driven Drug Development Product Overview
9.13.3 CytoReason Artificial Intelligence-driven Drug Development Product Market Performance
9.13.4 CytoReason Business Overview
9.13.5 CytoReason Recent Developments
9.14 Deep Genomics
9.14.1 Deep Genomics Artificial Intelligence-driven Drug Development Basic Information
9.14.2 Deep Genomics Artificial Intelligence-driven Drug Development Product Overview
9.14.3 Deep Genomics Artificial Intelligence-driven Drug Development Product Market Performance
9.14.4 Deep Genomics Business Overview
9.14.5 Deep Genomics Recent Developments
9.15 Cloud Pharmaceuticals
9.15.1 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Basic Information
9.15.2 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Product Overview
9.15.3 Cloud Pharmaceuticals Artificial Intelligence-driven Drug Development Product Market Performance
9.15.4 Cloud Pharmaceuticals Business Overview
9.15.5 Cloud Pharmaceuticals Recent Developments
9.16 BenevolentAI
9.16.1 BenevolentAI Artificial Intelligence-driven Drug Development Basic Information
9.16.2 BenevolentAI Artificial Intelligence-driven Drug Development Product Overview
9.16.3 BenevolentAI Artificial Intelligence-driven Drug Development Product Market Performance
9.16.4 BenevolentAI Business Overview
9.16.5 BenevolentAI Recent Developments
9.17 Cyclica
9.17.1 Cyclica Artificial Intelligence-driven Drug Development Basic Information
9.17.2 Cyclica Artificial Intelligence-driven Drug Development Product Overview
9.17.3 Cyclica Artificial Intelligence-driven Drug Development Product Market Performance
9.17.4 Cyclica Business Overview
9.17.5 Cyclica Recent Developments
9.18 Verge Genomics
9.18.1 Verge Genomics Artificial Intelligence-driven Drug Development Basic Information
9.18.2 Verge Genomics Artificial Intelligence-driven Drug Development Product Overview
9.18.3 Verge Genomics Artificial Intelligence-driven Drug Development Product Market Performance
9.18.4 Verge Genomics Business Overview
9.18.5 Verge Genomics Recent Developments
9.19 Valo Health
9.19.1 Valo Health Artificial Intelligence-driven Drug Development Basic Information
9.19.2 Valo Health Artificial Intelligence-driven Drug Development Product Overview
9.19.3 Valo Health Artificial Intelligence-driven Drug Development Product Market Performance
9.19.4 Valo Health Business Overview
9.19.5 Valo Health Recent Developments
9.20 Envisagenics
9.20.1 Envisagenics Artificial Intelligence-driven Drug Development Basic Information
9.20.2 Envisagenics Artificial Intelligence-driven Drug Development Product Overview
9.20.3 Envisagenics Artificial Intelligence-driven Drug Development Product Market Performance
9.20.4 Envisagenics Business Overview
9.20.5 Envisagenics Recent Developments
9.21 Euretos
9.21.1 Euretos Artificial Intelligence-driven Drug Development Basic Information
9.21.2 Euretos Artificial Intelligence-driven Drug Development Product Overview
9.21.3 Euretos Artificial Intelligence-driven Drug Development Product Market Performance
9.21.4 Euretos Business Overview
9.21.5 Euretos Recent Developments
9.22 BioAge Labs
9.22.1 BioAge Labs Artificial Intelligence-driven Drug Development Basic Information
9.22.2 BioAge Labs Artificial Intelligence-driven Drug Development Product Overview
9.22.3 BioAge Labs Artificial Intelligence-driven Drug Development Product Market Performance
9.22.4 BioAge Labs Business Overview
9.22.5 BioAge Labs Recent Developments
9.23 Iktos
9.23.1 Iktos Artificial Intelligence-driven Drug Development Basic Information
9.23.2 Iktos Artificial Intelligence-driven Drug Development Product Overview
9.23.3 Iktos Artificial Intelligence-driven Drug Development Product Market Performance
9.23.4 Iktos Business Overview
9.23.5 Iktos Recent Developments
9.24 BioSymetrics
9.24.1 BioSymetrics Artificial Intelligence-driven Drug Development Basic Information
9.24.2 BioSymetrics Artificial Intelligence-driven Drug Development Product Overview
9.24.3 BioSymetrics Artificial Intelligence-driven Drug Development Product Market Performance
9.24.4 BioSymetrics Business Overview
9.24.5 BioSymetrics Recent Developments
9.25 Evaxion Biotech
9.25.1 Evaxion Biotech Artificial Intelligence-driven Drug Development Basic Information
9.25.2 Evaxion Biotech Artificial Intelligence-driven Drug Development Product Overview
9.25.3 Evaxion Biotech Artificial Intelligence-driven Drug Development Product Market Performance
9.25.4 Evaxion Biotech Business Overview
9.25.5 Evaxion Biotech Recent Developments
9.26 Aria Pharmaceuticals
9.26.1 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Basic Information
9.26.2 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Product Overview
9.26.3 Aria Pharmaceuticals Artificial Intelligence-driven Drug Development Product Market Performance
9.26.4 Aria Pharmaceuticals Business Overview
9.26.5 Aria Pharmaceuticals Recent Developments
10 Artificial Intelligence-driven Drug Development Regional Market Forecast
10.1 Global Artificial Intelligence-driven Drug Development Market Size Forecast
10.2 Global Artificial Intelligence-driven Drug Development Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Artificial Intelligence-driven Drug Development Market Size Forecast by Country
10.2.3 Asia Pacific Artificial Intelligence-driven Drug Development Market Size Forecast by Region
10.2.4 South America Artificial Intelligence-driven Drug Development Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Artificial Intelligence-driven Drug Development by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Artificial Intelligence-driven Drug Development Market Forecast by Type (2025-2030)
11.2 Global Artificial Intelligence-driven Drug Development Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings
